Life Sciences
Top stories summarized by our editors
10/23/2018

The Gene Technology Regulator in Australia proposed that biotech plants, microbes and animals produced from SDN-1 technique should be exempted from regulation, saying that the changes that have been made to them could occur naturally. Bayer said that products derived from the technique are similar to those derived from conventional breeding techniques.

More Summaries:
Gene Technology, Bayer
10/23/2018

The Environmental Protection Agency was ordered by President Donald Trump to start the regulatory process for year-round use of E15 fuel. The EPA's proposal for this new process is expected in February, and the agency is slated to adopt the new fuel economy standards by March and the year-round blending rules by May.

10/23/2018

Eli Lilly and Co. kicked off its metastatic breast cancer awareness campaign by debuting a custom yoga pose on "Good Morning America." The Thriver Pose is part of the company's Thriver Movement for patients and features actress Mira Sorvino.

Full Story:
FiercePharma
10/23/2018

A round of financing has been closed by Earlens, generating $87 million in proceeds. The company will use the money for continued development and a next-generation version of its hearing aid technology.

Full Story:
MassDevice (Boston)
More Summaries:
EarLens
10/23/2018

A prospectus has been filed by Axonics Modulation Technologies for an initial public offering of an estimated 6.6 million shares of its common stock, priced at $14 to $16, in hopes of raising about $100 million at the midpoint. The company originally intended to raise $86 million in an offering.

Full Story:
Seeking Alpha
10/23/2018

Chembio Diagnostics will pay $5.5 million in cash for Germany-based OpTricon, which makes handheld analyzers for rapid diagnostic tests, under a deal expected to close Oct. 31. The company also has launched an underwritten public offering of common stock in hopes of raising $25 million to pay for the acquisition and fund its business growth strategy, as well as for general corporate purposes.

More Summaries:
Chembio Diagnostics
10/23/2018

A private placement of around 2.5 million shares of stock has pulled in around $4 million for Second Sight Medical. The company will use the proceeds for a number of initiatives associated with its Orion Cortical Visual Prosthesis System, as well as to continue development of its Argus II system and other next-generation artificial vision-related externals and add-ons.

Full Story:
MassDevice (Boston)
More Summaries:
Second Sight Medical
10/23/2018

A round of Series A equity financing has brought in $2.5 million for shoulder replacement system developer Shoulder Innovations. The proceeds will be used to advance development of new products, as well as for inventory and asset acquisitions to boost growth of the company's Inset platform technology.

Full Story:
FinSMEs
More Summaries:
Shoulder Innovations
10/23/2018

Aetna has agreed to provide coverage for use of Senseonics' Eversense continuous glucose monitor. The decision is effective immediately.

Full Story:
Seeking Alpha
More Summaries:
Aetna, Senseonics
10/23/2018

Brainlab has introduced the ExacTrac Dynamic -- the next-generation version of its ExacTrac X-Ray patient positioning and monitoring technology. The ExacTrac Dynamic is designed to improve treatment of moving targets by using 300,000 3D surface points to monitor patients and identify movement.

Full Story:
Compelo
More Summaries:
BrainLab